Atlas Trials

Clinical Response and Toxicity of Hypo-fractionated Chemoradiotherapy in Cervix Cancer

Clinical trial NCT04831437 · RECRUITING

Trial details

NCT number
NCT04831437
Sponsor
Tehran University of Medical Sciences
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Cervix Uteri Cancer
Start date
2021-04-01
Primary completion
2023-03-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.